tolvaptan has been researched along with Weight Loss in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Jiang, L; Li, M; Wan, Q; Yuan, F; Zhang, Y; Zhou, J | 1 |
| Enomoto, N; Gotou, T; Hayashi, T; Higuchi, M; Itakura, J; Izumi, N; Komiyama, Y; Kubota, Y; Kurosaki, M; Nakanishi, H; Oh, W; Okada, M; Takada, H; Takahashi, Y; Takaura, K; Tamaki, N; Yasui, Y | 1 |
| Cai, L; Wang, C; Xiong, B | 1 |
| Hiramatsu, A; Hiramine, Y; Iwamoto, T; Izumi, N; Kawaratani, H; Kimura, M; Koike, K; Nakanishi, H; Okita, K; Sakaida, I; Terai, S; Uojima, H; Uto, H; Yoshiji, H | 1 |
| Iida, Y; Shimizu, H; Yoshitake, A | 1 |
| Burnett, J; Gheorghiade, M; Grinfeld, L; Hauptman, PJ; Konstam, MA; Kostic, D; Krasa, HB; Maggioni, A; Ouyang, J; Swedberg, K; Udelson, JE; Zannad, F; Zimmer, C | 1 |
| Hew-Butler, T; Hummel, J; Rider, BC; Verbalis, JG | 1 |
| Hamano, T; Isaka, Y; Iwatani, H; Kawabata, H; Rakugi, H; Sakaguchi, Y; Yamamoto, R | 1 |
| Fujinaga, K; Ito, H; Mizumoto, T; Sawada, Y; Shimpo, H; Tempaku, H | 1 |
| Ehara, Y; Fujikawa, T; Fujita, M; Fujiwara, A; Hirawa, N; Kagimoto, M; Katsumata, M; Kobayashi, M; Kobayashi, Y; Okuyama, Y; Saka, S; Sumida, K; Tamura, K; Toya, Y; Umemura, S; Yamamoto, Y; Yasuda, G; Yatsu, K | 1 |
| Adams, KF; Barbagelata, A; Benza, RL; Elkayam, U; Gattis, WA; Ghali, JK; Gheorghiade, M; Klapholz, M; McGrew, FA; O'Connor, CM; Orlandi, C; Ouyang, J | 1 |
1 review(s) available for tolvaptan and Weight Loss
| Article | Year |
|---|---|
Effects of Tolvaptan in patients with acute heart failure: a systematic review and meta-analysis.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Dyspnea; Female; Heart Failure; Humans; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Recovery of Function; Sodium; Time Factors; Tolvaptan; Treatment Outcome; Weight Loss | 2017 |
4 trial(s) available for tolvaptan and Weight Loss
| Article | Year |
|---|---|
Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; China; Female; Fluid Shifts; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Tolvaptan; Torsemide; Treatment Outcome; Ultrafiltration; Urination; Weight Loss | 2020 |
Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan.
Topics: Aged; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuretics; Dyspnea; Female; Furosemide; Heart Failure, Systolic; Humans; Hyponatremia; Male; Middle Aged; Proportional Hazards Models; Tolvaptan; Weight Loss | 2013 |
Characterization of the effects of the vasopressin V2 receptor on sweating, fluid balance, and performance during exercise.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Deamino Arginine Vasopressin; Double-Blind Method; Exercise; Female; Hormone Antagonists; Humans; Male; Middle Aged; Neurophysins; Osmolar Concentration; Physical Endurance; Plasma Volume; Protein Precursors; Receptors, Vasopressin; Running; Signal Transduction; Sodium; Sweat; Sweat Glands; Sweating; Thirst; Time Factors; Tolvaptan; Vasopressins; Water-Electrolyte Balance; Weight Loss; Young Adult | 2014 |
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.
Topics: Ambulatory Care; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiovascular Agents; Diuretics; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Tolvaptan; Ventricular Dysfunction, Left; Weight Loss | 2004 |
6 other study(ies) available for tolvaptan and Weight Loss
| Article | Year |
|---|---|
Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weight; Diuretics; Female; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Potassium; Sodium; Tolvaptan; Treatment Outcome; Weight Loss | 2017 |
Response criteria of tolvaptan for the treatment of hepatic edema.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Dose-Response Relationship, Drug; Edema; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Reproducibility of Results; Retrospective Studies; ROC Curve; Severity of Illness Index; Tolvaptan; Treatment Outcome; Weight Loss; Young Adult | 2018 |
Safety and Effectiveness of Tolvaptan Administration after Total Arch Replacement.
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Aortic Aneurysm, Thoracic; Blood Vessel Prosthesis Implantation; Drug Administration Schedule; Drug Therapy, Combination; Female; Furosemide; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Retrospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Spironolactone; Time Factors; Tolvaptan; Treatment Outcome; Urination; Water-Electrolyte Balance; Weight Loss | 2019 |
Urine osmolarity predicts the body weight-reduction response to tolvaptan in chronic kidney disease patients: a retrospective, observational study.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Female; Heart Failure; Humans; Kidney Function Tests; Liver Cirrhosis; Male; Middle Aged; Osmolar Concentration; Renal Insufficiency, Chronic; Retrospective Studies; ROC Curve; Tolvaptan; Urodynamics; Weight Loss | 2015 |
Efficacy of Tolvaptan on Fluid Management After Cardiovascular Surgery Using Cardiopulmonary Bypass.
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Diuresis; Drug Administration Schedule; Female; Humans; Male; Oxygen Inhalation Therapy; Postoperative Care; Retrospective Studies; Tolvaptan; Urine; Water-Electrolyte Imbalance; Weight Loss | 2016 |
Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Diuretics; Female; Heart Failure; Humans; Kidney; Male; Middle Aged; Osmolar Concentration; Renal Elimination; Renal Insufficiency, Chronic; Retrospective Studies; Sodium; Time Factors; Tolvaptan; Treatment Outcome; Urine; Urodynamics; Weight Loss | 2017 |